In-Depth Insights into the Cell Lysis And Fractionation Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the cell lysis and fractionation market?
The market size for cell lysis and fractionation has seen considerable growth in recent years. This market is projected to expand from $3.42 billion in 2024 to $3.72 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. The strong growth seen in the past can be tied to several factors, including increased funding for life science research, an intensified focus on personalized healthcare, a high disease prevalence, advancements in cell lysis and fractionation technology, and a growing demand for biopharmaceuticals and biotech products.
What will be the cell lysis and fractionation market size in the future?
The market size for cell lysis and fractionation is projected to experience considerable growth in the coming years, expanding to $4.89 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. This predicted surge is associated with several factors such as the evolution of personalized medicine, increased government research funding, high demand for effective cell lysis and fractionation techniques, and improvements in genomics and proteomics technology. Additionally, the rising occurrence of both chronic and infectious diseases contributes to this growth. The forecast period will likely see continued growth in personalized medicine usage, increased incorporation of automation and robotics in lysis and fractionation procedures, proliferation of applications in clinical diagnostics and drug development, advancements in cell analysis methods like microfluidics and lab-on-a-chip technologies, and increasing focus on point-of-care and decentralized testing solutions.
Get your cell lysis and fractionation market report here!
https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report
What main drivers are fueling expansion in the cell lysis and fractionation market?
The expansion of the cell lysis and fractionation markets is anticipated to be fuelled by an increased emphasis on personalized medicine. Personalized medicine is a relatively new field that employs a person’s genetic profile for diagnosing and treating diseases. It customizes medical choices and procedures based on the specific attributes of each patient, with a particular emphasis on their genetic composition. Cell lysis and fractionation have a significant role in precision medicine as they allow for the isolation and examination of distinct subcellular components from patient specimens, such as proteins, organelles, and nucleic acids. This enables researchers and healthcare practitioners to study the molecular mechanisms underlying disease and design tailored treatments based on each patient’s unique molecular characteristics. For example, the Personalized Medicine Coalition (PMC), an American organization encouraging the comprehension and application of personalized medicine, reported in October 2022 that over 75,000 genetic testing products and 300 personalized medicines for various types of cancer, genetic rare diseases, and numerous chronic and infectious diseases will be available in the market. As a result, the increased emphasis on personalized medicine is propelling the growth of cell lysis and fractionation markets.
What key areas define the segmentation of the global cell lysis and fractionation market?
The cell lysis and fractionation market covered in this report is segmented –
1) By Type: Mammalian Cells, Microbial Cells
2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation
3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies
Subsegments:
1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines
2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp
Who are the dominant players expanding their reach in the cell lysis and fractionation market?
Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.
How are evolving market trends shaping cell lysis and fractionation Strategies?
Major players in the realm of cell lysis and fractionation are shifting their focus towards creating innovative solutions such as CGT (cell and gene therapy) viral vector lysis kits to secure a competitive advantage. These kits simplify the AAV (Adeno-associated virus) lysis process, enhancing standard operating procedures, quality management, and safety while bringing consistency to bioprocessing workflows. As an illustration, in July 2023, QIAGEN, a German firm renowned for its sample and assay technologies, unveiled its novel CGT Viral Vector Lysis Kit. This kit enables the calculation of virus titers for a variety of serotypes using a single, uniform technique beginning with cell lysates. QIAGEN’s latest offering joins its rapidly growing dPCR portfolio for the biotech industry, which presently consists of three QIAcuity Residual DNA Quantification Kits to examine host cell DNA residue, and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays intended for use in adeno-associated virus (AAV) titer quantification.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14064
Which regions are emerging as leaders in the cell lysis and fractionation market?
North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Environment Management, Compliance And Due Diligence Global Market Report 2024
Operating Systems & Productivity Software Publishing Global Market Report 2024
Pain Management Devices And Therapies Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
